Relationship between genetic polymorphisms of metabolizing enzymes CYP2E1, GSTM1 and Kazakh's esophageal squamous cell cancer in Xinjiang, China

World Journal of Gastroenterology

Volumn 11, Issue 24, 2005, Pages 3651-3654

  Lu, Xiao Mei ^a   Zhang, Yue Ming ^a   Lin, Ren Yong ^a   Gul, Arzi ^a   Wang, Xing ^a   Zhang, Ya Lou ^a   Zhang, Yan ^a   Wang, Yan ^a   Wen, Hao ^a  

^a XINJIANG MEDICAL UNIVERSITY   (China)

Author keywords

CYP2E1; GSTM1; Kazakh's esophageal squamous cell cancer; Polymorphisms

Indexed keywords

CYTOCHROME P450 2E1; GLUTATHIONE TRANSFERASE;

ADULT; AGED; ALLELE; ARTICLE; CANCER RISK; CHINA; CONTROLLED STUDY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; GENE DELETION; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; WILD TYPE;

EID: 23844434294     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v11.i24.3651     Document Type: Article

References (35)

1. Mucci LA, Wedren S, Tamimi RM, Trichopoulos D, Adami HO. The role of gene-environment interaction in the aetiology of human cancer: examples from cancers of the large bowel, lung and breast. J Intern Med 2001; 249: 477-493
2. Kihara M, Kihara M, Noda K. Risk of smoking for squamous and small cell carcinomas of the lung modulated by combinations of CYP1A1 and GSTM1 gene polymorphisms in a Japanese population. Carcinogenesis 1995; 16: 2331-2336
3. Guengerich FP. Roles of cytochrome P-450 enzymes in chemical carcinogenesis and cancer chemotherapy. Cancer Res 1988; 48: 2946-2954
4. Sram RJ. Effect of glutathione S-transferase M1 polymorphisms on biomarkers of exposure and effects. Environ Health Perspect 1998; 106(Suppl): 231-239
5. Wang LD, Zhou Q, Feng CW, Liu B, Qi YJ, Zhang YR, Gao SS, Fan ZM, Zhou Y, Yang CS, Wei JP, Zheng S. Intervention and follow-up on human esophageal precancerous lesions in Henan,northern China, a high-incidence area for esophageal cancer. Jpn J Cancer Chemother 2002; 29(Suppl): 159-172
6. Zhang YM. The distribution of esophageal cancer in Xinjiang. Xinjiang Yixueyuan Xuebao 1988; 11: 139-144
7. Diffenbach CW, Dveksler GS. PCR Primer: A Laboratory Manual. Cold Spring Harbor Laboratory Press 1995: 64-69
8. Hayashi S, Watanabe J, Kawajiri K. Genetic polymorphisms in the 5′-flanking region change transcriptional regulation of the human cytochrome P450IIE1 gene. J Biochem 1991; 110: 559-565
9. Casson AG, Zheng Z, Chiasson D, MacDonald K, Riddell DC, Guernsey JR, Guernsey DL, McLaughlin J. Associations between genetic polymorphisms of Phase I and II metabolizing enzymes, p53 and susceptibility to esophageal adenocarcinoma. Cancer Detect Prev 2003; 27: 139-146
10. Tan W, Song N, Wang GQ, Liu Q, Tang HJ, Kadlubar FF, Lin DX. Impact of genetic polymorphisms in cytochrome P450 2E1 and glutathione S-transferases M1, T1, and P1 on susceptibility to esophageal cancer among high-risk individuals in China. Cancer Epidemiol Biomarkers Prev 2000; 9: 551-556
11. Van Lieshout EM, Roelofs HM, Dekker S, Mulder CJ, Wobbes T, Jansen JB, Peters WH. Polymorphic expression of the glutathione S-transferase P1 gene and its susceptibility to Barrett's esophagus and esophageal carcinoma. Cancer Res 1999; 59: 586-589
12. Roth MJ, Dawsey SM, Wang G, Tangrea JA, Zhou B, Ratnasinghe D, Woodson KG, Olivero CA, Poirier MC, Frye BL, Taylor PR, Weston A. Association between GSTM1*0 and squamous dysplasia of the esophagus in the high risk region of Linxian, China. Cancer Lett 2000; 156: 73-81
13. Butler WJ, Ryan P, Roberts-Thomson IC. Metabolic genotypes and risk for colorectal cancer. J Gastroenterol Hepatol 2001; 16: 631-635
14. Xing D, Tan W, Song N, Lin D. Genetic polymorphism in hOGG1and susceptibility to esophageal cancer in Chinese. Zhonghuayixue Yichuanxue Zazhi 2000; 17: 377-380
15. Song C, Xing D, Tan W, Wei Q Lin D. Methylenetetrahydrofolate reductase polymorphisms increase risk of esophageal squamous cell carcinoma in a Chinese population. Cancer Res 2001; 61: 3272-3275
16. Lee JM, Lee YC, Yang SY, Yang PW, Luh SP, Lee CJ, Chen CJ, Wu MT. Genetic polymorphisms of XRCC1 and risk of the esophageal cancer. Int J Cancer 2001; 95: 240-246
17. Tan W, Chen GF, Xing DY, Song CY, Kadlubar FF, Lin DX. Frequency of CYP2A6 gene deletion and its relation to risk of lung and esophageal cancer in the Chinese population. Int J Cancer 2001; 93: 96-101
18. Shibuta J, Eto T, Kataoka A, Inoue H, Ueo H, Suzuki T, Barnard GF, Mori M. Genetic polymorphism of N-acetyltransferase 2 in patients with esophageal cancer. Am J Gastroenterol 2001; 96: 3419-3424
19. Matsuo K, Hamajima N, Shinoda M, Hatooka S, Inoue M, Takezaki T, Tajima K. Gene-environment interaction between an aldehyde dehydrogenase-2 (ALDH2) polymorphism and alcohol consumption for the risk of esophageal cancer. Carcinogenesis 2001; 22: 913-916
20. Dong CH, Yu SZ, Chen GC, Zhao DM, Hu Y. Association of polymorphisms of glutathdone S transferase M1 and T1 genotypes with elevated aflatoxin and increased risk of primary liver cancer. Shifie Huaren Xiaohua Zazhi 1998; 6: 463-466
21. Cai L, Yu SZ. A molecular epidemiologic study on gastric cancer in Changle, Fujian province. Shifie Huaren Xiaohua Zazhi 1999; 7: 652-655
22. Gao J, Ren CL, Zhang Q. CYP2D6 and GSTM1 genetic polymorphism and lung cancer susceptibility. Zhonghua Zhongliu Zazhi 1998; 20: 185-186
23. Cai L, Yu SZ. Preliminary studies on cytochrome P4502E1 and Glutathione Stransferase M1 polymorphisms and susceptibility to gastric cancer. Zhongguo Gonggong Weisheng 1999; 15: 895-897
24. Lin D, Tang Y, Lu S. Glutathione S-transferase M1, T1genetypes and risks of esophageal cancer: a case-control study. Zhonghua Liuxingbing Zazhi 1998; 19: 195-199
25. Gao CM, Takezaki T, Wu JZ, Li ZY, Liu YT, Li SP, Ding JH, Su P, Hu X, Xu TL, Sugimura H, Tajima K. Glutathione-S-transferases M1 (GSTM1) and GSTT1 genotype, smoking, consumption of alcohol and tea and risk of esophageal and stomach cancers: a case-control study of a high-incidence area in Jiangsu Province, China. Cancer Lett 2002; 188: 95-102
26. Bellec G, Dreano Y, Lozach P, Menez JF, Berthou. F. Cytochrome P450 metabolic dealkylation of nine N-nitrosodialk-ylamines by human liver microsomes. Carcinogenesis 1996; 17: 2029-2034
27. Hecht SS. Tobacco smoke carcinogens and lung cancer. J Natl Cancer Inst 1999; 91: 1194-1210
28. Ekstrom G, Ingelman-Sundberg M. Rat liver microsomal NADPH-supported oxidase activity and lipid peroxidation dependent on ethanol-inducible cytochrome P-450 (P-450IIE1). Biochem Harmacol 1989; 38: 1313-1319
29. Nishimoto IN, Hanaoka T, Sugimura H, Nagura K, Ihara M, Li XJ, Arai T, Hamada GS, Kowalski LP, Tsugane S. Cytochrome P450 2E1 polymorphism in gastric cancer in Brazil: case-control studies of Japanese Brazilians and non-Japanese Brazilians. Cancer Epidemiol Biomarkers Prev 2000; 9: 675-680
30. Shi Y, Zhou XW, Zhou YK, Ren X. Analysis of CYP2 E1, gSTM1 genetic polymorphisms in relation to human lung cancer and esophageal carcinoma. J Huazhong Univ Sci Tech 2002; 31: 14-17
31. Itoga S, Nomura F, Makino Y, Tomonaga T, Shimada H, Ochiai T, Iizasa T, Baba M, Fujisawa T, Harada S. Tandem repeat polymorphism of the CYP2E1 gene: an association study with esophageal cancer and lung cancer. Alcohol Clin Exp Res 2002; 26(8 Suppl): 15S-19
32. Godoy W, Albano RM, Moraes EG, Pinho PR, Nunes RA, Saito EH, Higa. C, Filho IM, Kruel CD, Schirmer CC, Gurski R, Lang MA, Pinto LF. CYP2A6/2A7 and CYP2E1 expression in human oesophageal mucosa: regional and inter-individual variation in expression and relevance to nitrosamine metabolism. Carcinogenesis 2002; 23: 611-616
33. Gao CM, Li SP, Su P, Li ZY, Wan JD, Hu X, Wu JZ, Ding JH, Liu YL. The Impact of CYP2E1 Rsa I, GSTT1 and GSTM1 polymorphisms on the risk of esophageal cancer. China J Cancer 2001; 10: 346-349
34. Ribeiro Pinto LF, Teixeira Rossini AM, Albano RM, Felzenszwalb I, de Moura Gallo CV, Nunes RA, Andreollo NA. Mechanisms of esophageal cancer development in Brazilians. Mutat Res 2003; 544: 365-373
35. Casson AG, Zheng Z, Chiasson D, MacDonald K, Riddell DC, Guernsey JR, Guernsey DL, McLaughlin J. Associations between genetic polymorphisms of Phase I and II metabolizing enzymes, p53 and susceptibility to esophageal adenocarcinoma. Cancer Detect Prev 2003; 27: 139-146